China NMPA Product Recall - Portable automated peritoneal dialysis machine

On July 17, 2013, the National Medical Products Administration (NMPA) published information regarding a voluntary recall initiated by Baxter Healthcare Corporation, through its Chinese subsidiary, Baxter Medical Supplies Trading (Shanghai) Co., Ltd. The recall, reported on May 23, 2013, involves its portable automated peritoneal dialysis machines, specifically the Homechoice Model 5C4474, impacting 439 units in China. The primary issue identified was an increase in intraperitoneal fluid (IIPV) experienced by patients during the use of the device. Although initial findings suggested patient misuse or incorrect formulation contributed to these incidents in markets outside China, Baxter opted for a proactive global software upgrade to mitigate potential risks. Operating under the NMPA's regulatory framework for medical devices, Baxter's required actions include a comprehensive software upgrade of all affected HomeChoice machines to version 10.4, performed by their engineers. Additionally, Baxter committed to drafting and issuing a "Customer Communication Letter" to inform users about this upgrade. The NMPA requested all regional food and drug administrations to enhance supervision of similar products. This recall underscores a commitment to patient safety through device modification and transparent communication.